TLIS Investors Have Opportunity to Lead Talis Biomedical Corporation Securities Fraud LawsuitPRNewsWire • 02/22/22
Investor Notice: March 8th Deadline for Investors who Lost over $100,000 in Talis Biomedical Corporation shares announced by Shareholders FoundationPRNewsWire • 02/22/22
ROSEN, A Top Ranked Law Firm, Encourages Talis Biomedical Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - TLISNewsfile Corp • 02/21/22
ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Talis Biomedical Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - TLISPRNewsWire • 02/21/22
Securities Class Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Talis Biomedical Corporation Investors of Upcoming Deadline in Securities Fraud Class Action LawsuitNewsfile Corp • 02/21/22
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Talis Biomedical Corporation - TLISPRNewsWire • 02/20/22
TLIS Reminder: Kessler Topaz Meltzer & Check, LLP - March 8, 2022 Lead Plaintiff Deadline Reminder for Talis Biomedical Corporation InvestorsPRNewsWire • 02/19/22
Important March 8, 2022 Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Talis Biomedical Corporation Investors of Securities Fraud Class Action LawsuitNewsfile Corp • 02/17/22
TLIS INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Talis Biomedical Corporation (TLIS) Investors with Losses to Contact Firm's Attorneys, Securities Fraud Action PendingNewsfile Corp • 02/16/22
ROSEN, Global Investor Counsel, Encourages Talis Biomedical Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - TLISNewsfile Corp • 02/15/22
Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Talis Biomedical CorporationNewsfile Corp • 02/12/22
TLIS CLASS ACTION: Kessler Topaz Meltzer & Check, LLP Reminds Talis Biomedical Corporation Shareholders of Securities Fraud Class Action LawsuitPRNewsWire • 02/11/22
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Talis Biomedical Corporation Investors with Losses to Secure Counsel Before Important March 8 Deadline in Securities Class Action - TLISPRNewsWire • 02/11/22
Shareholder Action Reminder: The Schall Law Firm Encourages Investors in Talis Biomedical Corporation with Losses of $100,000 to Contact the FirmNewsfile Corp • 02/10/22
Talis Biomedical Corporation Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Important Lead Plaintiff Deadline on March 8, 2022 in Securities Fraud Class Action LawsuitNewsfile Corp • 02/09/22
TLIS INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Talis Biomedical Corporation (TLIS) Investors with Losses to Contact Firm's Attorneys About Lead Plaintiff OpportunityNewsfile Corp • 02/09/22
Investor Action Alert: The Schall Law Firm Encourages Investors in Talis Biomedical Corporation with Losses of $100,000 to Contact the FirmNewsfile Corp • 02/08/22
Class Action Lawsuit Deadline: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Talis Biomedical CorporationNewsfile Corp • 02/04/22
TLIS Shareholder Alert: Rosen, Top Ranked National Investor Attorneys, Encourages Talis Biomedical Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - TLISNewsfile Corp • 02/04/22
Kirby McInerney LLP Reminds Investors That a Securities Class Action Lawsuit Has Been Filed on Behalf of Talis Biomedical Corporation (TLIS) Investors and Encourages Investors to Contact the Firm Before March 8, 2022Business Wire • 02/04/22
Investor Action Reminder: The Schall Law Firm Encourages Investors in Talis Biomedical Corporation with Losses of $100,000 to Contact the FirmNewsfile Corp • 02/03/22
ROSEN, A LEADING LAW FIRM, Encourages Talis Biomedical Corporation Investors to Secure Counsel Before Important March 8 Deadline in Securities Class Action - TLISPRNewsWire • 02/02/22
TLIS ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of March 8, 2022 in the Class Action Filed on Behalf of Talis Biomedical Corporation Limited ShareholdersPRNewsWire • 02/01/22
TLIS Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Talis Biomedical Corporation Investors of Class Action and Lead Deadline: March 8, 2022Newsfile Corp • 02/01/22
INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Lead Plaintiff Deadline on March 8, 2022 in Securities Fraud Class Action Lawsuit Filed Against Talis Biomedical CorporationNewsfile Corp • 01/28/22